What Follistatin-344 is
Follistatin-344 is discussed in relation to myostatin and activin pathway regulation, especially in muscle-growth narratives.
Follistatin-344 is grouped under Fitness + Recovery on PeptideFactCheck because the public hook is obvious: people see follistatin as a route to myostatin suppression and more muscle growth.
The useful starting point is to separate the molecule itself from the internet story around it. The public hook is obvious: people see follistatin as a route to myostatin suppression and more muscle growth.
Why people keep looking it up
The public hook is obvious: people see follistatin as a route to myostatin suppression and more muscle growth.
Follistatin-344 is discussed in relation to myostatin and activin pathway regulation, especially in muscle-growth narratives.
Follistatin-344 tends to stay in the conversation because it touches a familiar public theme: myostatin pathway, muscle regulation, and tgf-beta family. That makes it easy for the claim to travel faster than the evidence.
What the evidence can support right now
Strong mechanistic appeal, weak direct clinical support for the popular use case.
That muscle-growth narrative is much stronger online than in direct human peptide evidence.
Most of the signal comes from pathway biology, animal work, and gene-therapy-adjacent discussions rather than product-level trials.
Why this page carries the current tier: Strong mechanistic appeal, weak direct clinical support for the popular use case.
The current seed trail for Follistatin-344 is pulling from 1 literature source, 1 trials source, and 1 databases source.
Safety, limits, and regulatory context
Myostatin-pathway manipulation is biologically consequential and the long-term risk profile is not simple.
No FDA-approved follistatin-344 peptide product is represented in this seed set.
Editorial boundary: PeptideFactCheck does not publish dosing, cycling, sourcing, injection, or administration instructions for Follistatin-344. The job here is to explain the public claim, the mechanism story, the evidence strength, and the current limits.
Clinical trial snapshot
The current ClinicalTrials.gov intervention query for Follistatin-344 returns 1 study records. This does not prove efficacy by itself, but it does show whether the peptide is showing up in a formal trial registry rather than only in forums or vendor copy.
Literature snapshot
The current PubMed query for Follistatin-344 returns 5 results. The articles below are a quick literature surface so the page shows actual papers instead of only generic evidence labels.
Source trail
Each linked source is shown directly so the page can be audited. The page now combines its editorial seed trail with automated official-source enrichment generated on 2026-04-24 from PubChem, ClinicalTrials.gov, PubMed, DailyMed, openFDA label, and Drugs@FDA.